[Criticism against the atenolol meta-analysis remains].
Forsén
Kent
K
kent.forsen.mma@telia.com
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D015201:Meta-Analysis as Topic
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001262:Atenolol